Evidence map›Paper›PMID 34547899›Full record

ArticleMolecular pharmaceutics2021

Lipid Cubic Systems for Sustained and Controlled Delivery of Antihistamine Drugs.

Michele Dully, Miriama Ceresnakova, David Murray, Tewfik Soulimane, Sarah P Hudson

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michele DullyDepartment of Chemical Sciences, SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Castletroy, Co. Limerick V94 T9PX, Ireland.
Miriama CeresnakovaDepartment of Chemical Sciences, SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Castletroy, Co. Limerick V94 T9PX, Ireland.
David MurrayCOOK Ireland Limited, O'Halloran Rd, Castletroy, Co. Limerick V94 N8X2, Ireland.
Tewfik SoulimaneDepartment of Chemical Sciences, SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Castletroy, Co. Limerick V94 T9PX, Ireland.
Sarah P HudsonDepartment of Chemical Sciences, SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, Bernal Institute, University of Limerick, Castletroy, Co. Limerick V94 T9PX, Ireland.ORCID 0000-0002-6718-2190
Science Foundation Ireland · IECook Medical (Ireland) · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antihistamines are capable of blocking mediator responses in allergic reactions including allergic rhinitis and dermatological reactions. By incorporating various H

Indexed as

Drug Delivery SystemsHistamine AntagonistsHumansLipid BilayersNasal MucosaHistamine AntagonistsLipid Bilayersantihistaminescontrolled deliveryhydrophobic active pharmaceuticalslipid cubic phasemucoadhesionSAXS

Identifiers

PMID34547899
PMCPMC8493555
OpenAlexW3200381332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.